Nutritional compositions comprising spore-forming probiotics

Patent metadata

Field	Value
Publication number	US-2016353774-A1
Application number	US-201514727978-A
Country	US
Kind code	A1
Filing date	Jun 2, 2015
Priority date	Jun 2, 2015
Publication date	Dec 8, 2016
Grant date	—

Abstract

Disclosed are nutritional compositions for pediatric subjects, such as children's nutritional products and infant formulas, which include a protein or protein equivalent source, a fat, a carbohydrate, and a spore-forming probiotic.

First claim

What is claimed is:

1 . A nutritional composition for a pediatric subject, comprising:
a fat; a carbohydrate; a protein or protein equivalent source source; and a spore-forming probiotic.

2 . The nutritional composition of claim 1 , wherein the spore-forming probiotic comprises Bacillus coagulans.

3 . The nutritional composition of claim 2 , wherein the nutritional composition comprises at least 1×10 6 cfu Bacillus coagulans per 100 kcal nutritional composition.

4 . The nutritional composition of claim 3 , wherein the nutritional composition comprises Bacillus coagulans in the range of about 1×10 6 cfu to about 1×10 9 cfu per 100 kcal nutritional composition.

5 . The nutritional composition of claim 1 , further comprising a prebiotic.

6 . The nutritional composition of claim 5 , wherein the prebiotic comprises polydextrose and galacto-oligosaccharide.

7 . The nutritional composition of claim 1 , further comprising at least one long chain polyunsaturated fatty acid.

8 . The nutritional composition of claim 7 , wherein the long chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid, arachidonic acid, or combinations thereof.

9 . The nutritional composition of claim 8 , wherein the ratio of arachidonic acid:docosahexaenoic acid by weight is from about 1:3 to about 9:1.

10 . The nutritional composition of claim 1 , wherein the nutritional composition is an infant formula.

11 . A method for enhancing immune function of a pediatric subject by administering to the pediatric subject a nutritional composition, comprising:
a fat; a carbohydrate; a protein or protein equivalent source; a prebiotic; and a spore-forming probiotic, wherein the administration of the nutritional composition enhances the immune function of the pediatric subject.

12 . The method of claim 11 , wherein the spore-forming probiotic comprises Bacillus coagulans.

13 . The method of claim 12 , wherein the nutritional composition comprises at least 1×10 6 cfu Bacillus coagulans per 100 kcal nutritional composition.

14 . The method of claim 13 , wherein the nutritional composition comprises Bacillus coagulans in the range of about 1×10 6 cfu to about 1×10 dcfu per 100 kcal nutritional composition.

15 . The method of claim 11 , further comprising a prebiotic, wherein the prebiotic comprises polydextrose and galacto-oligosaccharide.

16 . The method of claim 11 , further comprising at least one long chain polyunsaturated fatty acid selected from the group consisting of docosahexaenoic acid, arachidonic acid, or combinations thereof.

17 . The method of claim 11 , wherein the nutritional composition is an infant formula.

Assignees

• Mead Johnson Nutrition Co

Inventors

• Gonzalez Juan M

Classifications

• A23L33/26

  Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose · CPC title

• A23L33/17 Primary

  Amino acids, peptides or proteins · CPC title

• A23L33/10

  using additives (addition of substantially indigestible substances A23L33/21) · CPC title

• A23L33/12

  Fatty acids or derivatives thereof · CPC title

• A23L33/135

  Bacteria or derivatives thereof, e.g. probiotics · CPC title